{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:36:07Z","timestamp":1793136967112,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jaad.2026.07.008","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:02:24Z","timestamp":1783378944000},"page":"1399-1406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Atypical fibroxanthoma, pleomorphic dermal sarcoma, and undifferentiated sarcoma: Updates on diagnosis, management, and surveillance"],"prefix":"10.1016","volume":"95","author":[{"given":"Jason S.","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sarah","family":"Erem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan H.","family":"Trager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Breneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaira Z.","family":"Aasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murad","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Tyler","family":"Hollmig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teo","family":"Soleymani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro A.","family":"Gru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faramarz H.","family":"Samie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.07.008_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.det.2019.02.001","article-title":"Atypical fibroxanthoma and pleomorphic dermal sarcoma: updates on classification and management","volume":"37","author":"Soleymani","year":"2019","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2026.07.008_bib2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jaad.2018.06.048","article-title":"Atypical fibroxanthoma: systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision","volume":"79","author":"Tolkachjov","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.07.008_bib3","series-title":"Atypical Fibroxanthoma","author":"Kolb","year":"2025"},{"key":"10.1016\/j.jaad.2026.07.008_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13962","article-title":"Atypical fibroxanthoma: an analysis of 105 tumors","volume":"33","author":"Bitel","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2026.07.008_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1524-4725.2010.01843.x","article-title":"Atypical fibroxanthoma: a review of the literature","volume":"37","author":"Iorizzo","year":"2011","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.07.008_bib6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/modpathol.2017.146","article-title":"Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1\/2 and FAT1 mutations and similar DNA copy number alteration profiles","volume":"31","author":"Griewank","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1524-4725.2011.02180.x","article-title":"Clinical spectrum of atypical fibroxanthoma and undifferentiated pleomorphic sarcoma in solid organ transplant recipients: a collective experience","volume":"38","author":"McCoppin","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.07.008_bib8","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/PAS.0b013e31825359e1","article-title":"Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma","volume":"36","author":"Miller","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jaad.2023.08.050","article-title":"Atypical fibroxanthoma and pleomorphic dermal sarcoma: local recurrence and metastasis in a nationwide population-based cohort of 1118 patients","volume":"89","author":"Orholt","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.07.008_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00000478-199203000-00001","article-title":"Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma","volume":"16","author":"Fletcher","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/01.MP.0000056983.78547.77","article-title":"Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma","volume":"16","author":"Coindre","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/modpathol.3800794","article-title":"Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma","volume":"20","author":"Nakayama","year":"2007","journal-title":"Mod Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2026.07.008_bib13","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1038\/modpathol.2013.174","article-title":"An approach to pleomorphic sarcomas: can we subclassify, and does it matter?","volume":"27","author":"Goldblum","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib14","volume":"Vol 3","year":"2020"},{"key":"10.1016\/j.jaad.2026.07.008_bib15","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1200\/JCO.2001.19.12.3045","article-title":"Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification","volume":"19","author":"Fletcher","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2026.07.008_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.109747","article-title":"Subcutaneous undifferentiated pleomorphic sarcoma is more aggressive than pleomorphic dermal sarcoma: prognosis from a Danish nationwide registry-based cohort","volume":"51","author":"Orholt","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jaad.2026.07.008_bib17","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3390\/cancers17111785","article-title":"Molecular characterization of atypical fibroxanthoma and pleomorphic dermal sarcoma","volume":"17","author":"Klein","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaad.2026.07.008_bib18","first-page":"11","article-title":"Ultraviolet-induced p53 mutations in atypical fibroxanthoma","volume":"145","author":"Dei Tos","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib19","doi-asserted-by":"crossref","first-page":"21763","DOI":"10.18632\/oncotarget.7845","article-title":"Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas","volume":"7","author":"Helbig","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaad.2026.07.008_bib20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/modpathol.2013.168","article-title":"TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas","volume":"27","author":"Griewank","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.humpath.2020.06.003","article-title":"A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations","volume":"102","author":"Miller","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13569-019-0113-6","article-title":"Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotype","volume":"9","author":"Koelsche","year":"2019","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.jaad.2026.07.008_bib23","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2017.10.014","article-title":"Comprehensive and integrated genomic characterization of adult soft tissue sarcomas","volume":"171","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2026.07.008_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103131","article-title":"High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies","volume":"62","author":"Toulmonde","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaad.2026.07.008_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/DAD.0b013e3181c80b97","article-title":"Atypical fibroxanthoma: a histological and immunohistochemical review of 171 cases","volume":"32","author":"Beer","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cup.13787","article-title":"Atypical fibroxanthoma and pleomorphic dermal sarcoma: a reappraisal","volume":"48","author":"Cesinaro","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.path.2023.06.007","article-title":"Pleomorphic dermal sarcoma","volume":"17","author":"Saleh","year":"2024","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.jaad.2026.07.008_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1600-0560.2006.00635.x","article-title":"Immunohistochemical staining of CD10 in atypical fibroxanthomas","volume":"34","author":"Hultgren","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib29","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1600-0560.2011.01768.x","article-title":"The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma","volume":"38","author":"Wieland","year":"2011","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib30","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/DAD.0000000000002305","article-title":"Immunohistochemical characteristics of atypical fibroxanthoma and pleomorphic dermal sarcoma: a systematic review and meta-analysis","volume":"44","author":"Orholt","year":"2022","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib31","first-page":"1581","article-title":"Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers","volume":"20","author":"Kuntz","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2026.07.008_bib32","article-title":"MDM2 amplified sarcomas: a literature review","volume":"11","author":"Sciot","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jaad.2026.07.008_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.32074\/1591-951X-213","article-title":"The 2020 WHO classification of soft tissue tumours: news and perspectives","volume":"113","author":"Sbaraglia","year":"2021","journal-title":"Pathologica"},{"key":"10.1016\/j.jaad.2026.07.008_bib34","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/jum.16478","article-title":"The usefulness of ultrasonography for supporting the differentiation, diagnosis, and treatment of atypical fibroxanthoma and pleomorphic dermal sarcoma","volume":"43","author":"Crisan","year":"2024","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.jaad.2026.07.008_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00042728-200502000-00019","article-title":"Metastasizing atypical fibroxanthoma (cutaneous malignant histiocytoma): report of five cases","volume":"31","author":"Cooper","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.07.008_bib36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/1097-0142(19860115)57:2<368::AID-CNCR2820570230>3.0.CO;2-N","article-title":"Atypical fibroxanthoma of the skin with metastasis","volume":"57","author":"Helwig","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2026.07.008_bib37","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/archderm.1978.01640220082023","article-title":"Metastasizing atypical fibroxanthoma. Coexistence with chronic lymphocytic leukemia","volume":"114","author":"Kemp","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2026.07.008_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/cup.12603","article-title":"Pleomorphic dermal sarcoma: a more aggressive neoplasm than previously estimated","volume":"43","author":"Tard\u00edo","year":"2016","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib39","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.bjoms.2020.09.007","article-title":"Pleomorphic dermal sarcoma: a clinical and histological review of 49 cases","volume":"59","author":"Bowe","year":"2021","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.jaad.2026.07.008_bib40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jcp-2022-208570","article-title":"Prognostic factors for pleomorphic dermal sarcoma: analysis of 1911 cases from the SEER database","volume":"76","author":"Perez","year":"2023","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaad.2026.07.008_bib41","doi-asserted-by":"crossref","first-page":"e759","DOI":"10.1093\/oncolo\/oyac141","article-title":"Lethal dermal sarcoma in immunosuppressed patients","volume":"27","author":"Azin","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.jaad.2026.07.008_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.873771","article-title":"Hemato-oncological diseases as risk factor for recurrence or metastasis of pleomorphic dermal sarcoma","volume":"12","author":"Helbig","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaad.2026.07.008_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamadermatol.2013.6675","article-title":"Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system","volume":"150","author":"Schmitt","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.07.008_bib44","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3390\/cancers14071693","article-title":"A multidisciplinary approach to complex dermal sarcomas ensures an optimal clinical outcome","volume":"14","author":"Trostrup","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaad.2026.07.008_bib45","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jaad.2021.09.036","article-title":"Surgical excision margins for fibrohistiocytic tumors, including atypical fibroxanthoma and undifferentiated pleomorphic sarcoma: a probability model based on a systematic review","volume":"87","author":"Jibbe","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.07.008_bib46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jdin.2023.06.003","article-title":"Mohs micrographic surgery versus wide local excision for the treatment of atypical fibroxanthoma: a retrospective cohort analysis","volume":"12","author":"Meyer","year":"2023","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaad.2026.07.008_bib47","article-title":"Local relapse and survival outcomes in patients with scalp sarcoma: a retrospective study of 95 patients treated in a provincial cancer care institution over 25 years","volume":"11","author":"Jasper","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.jaad.2026.07.008_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.975342","article-title":"Immune checkpoint inhibitors for unresectable or metastatic pleomorphic dermal sarcomas","volume":"12","author":"Helbig","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaad.2026.07.008_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omz138","article-title":"Response to anti-PD1 immunotherapy in patients with metastatic cutaneous sarcoma: case reports and literature review","volume":"2020","author":"Vieira","year":"2020","journal-title":"Oxf Med Case Rep"},{"key":"10.1016\/j.jaad.2026.07.008_bib50","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S1470-2045(17)30624-1","article-title":"Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial","volume":"18","author":"Tawbi","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2026.07.008_bib51","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(24)01812-9","article-title":"Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial","volume":"404","author":"Mowery","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2026.07.008_bib52","article-title":"Monitoring response using circulating tumor DNA in undifferentiated pleomorphic sarcoma: a case report","volume":"16","author":"Siy","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jaad.2026.07.008_bib53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/cancers17010010","article-title":"Novel therapeutics in soft tissue sarcoma","volume":"17","author":"Mavroeidis","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaad.2026.07.008_bib54","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up(\u2217)","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2026.07.008_bib55","first-page":"235","article-title":"S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS)","volume":"20","author":"Helbig","year":"2022","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226030732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226030732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:30:44Z","timestamp":1793136644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226030732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0190962226030732"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.07.008","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical fibroxanthoma, pleomorphic dermal sarcoma, and undifferentiated sarcoma: Updates on diagnosis, management, and surveillance","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}